Tag: Heart / Stroke-Related: Misc.
No Increase in In-Hospital, Post-Discharge Death With HRRP
No increase in mortality seen with Hospital Readmissions Reduction Program implementation
Morbidity, Mortality Up for Youth With CHD Presenting to ED
Children with congenital heart disease presenting to ED at increased risk for morbidity, mortality
Lixisenatide Cuts Kidney Damage in T2DM and Coronary Syndrome
Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria
Albiglutide Beats Placebo for Cardiovascular Events in T2DM
Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events
Elevated Blood Pressure Linked to Aortic Valve Disease
Increased risk for aortic valve stenosis and aortic regurgitation with increased systolic BP
Preventable Cardiovascular Events Are Big Economic Burden
About 16.3 million events, totaling $173.7 billion in hospitalization costs, could occur in 2017 to 2021
September 2018 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for September 2018. This roundup includes the latest...
Strategies to Cut Cardiovascular Risk Factors Show Mixed Results
Concerted efforts needed to implement prevention strategies and reach Million Hearts prevention goals
Cardioverter-Defibrillator Vests Do Not Cut Sudden Death Post MI
No drop in arrhythmic death among patients with acute MI, ejection fraction of less than 35 percent
Increased Cardiovascular Risk for Diclofenac Initiators
Increased risk compared with NSAID non-initiators, initiators of acetaminophen, ibuprofen, naproxen
